vaccin.me
Media pushes success of GSK malaria vaccine while ignoring deadly side effects
Mainstream media is excited over GlaxoSmithKline’s latest offering, a malaria trial vaccine that the company claims can cut the risk of clinical and severe malaria in children by 56% and 47%,…